Oedema Clinical Trial
Official title:
Does Neuromuscular Electrical Stimulation (NMES) Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?
Neuromuscular Electrical Stimulation (NMES) will be facilitated through the use of a
stimulator, with the patient in a semi recumbent position, using UltraStim electrodes. Two 5
cm x 5 cm electrodes will be placed over the soleus muscle for calf stimulation. The
participant will be allowed to ramp up the stimulus level themselves to get used to the
sensation and determine their maximum tolerated stimulus level.
A goniometer will be used to assess mobility at the knee and ankle joints. Transcutaneous
oxygen measurements (tcpO2) will be assessed using the PERIMED Periflux System 500 tcpO2
monitor.
The level of oedema will be measured using the figure of eight measurement, tape
circumference measurement and water displacement measurement.
Comfort will also be assessed by use of a 100mm non-hatched visual analogue scale (VAS).
Each participant will be asked to indicate their level of comfort following the application
of NMES.
Neuromuscular Electrical Stimulation (NMES) will be facilitated through the use of a
two-channel, research stimulator, with the patient in a semi recumbent position, using
UltraStim electrodes. Two 5 cm x 5 cm electrodes will be placed over the soleus muscle for
calf stimulation. The participant will be allowed to ramp up the stimulus level themselves
to get used to the sensation and determine their maximum tolerated stimulus level.
A goniometer will be used to assess mobility at the knee and ankle joints. Transcutaneous
oxygen measurements (tcpO2) will be assessed using the PERIMED Periflux System 500 tcpO2
monitor.
The level of oedema will be measured using the figure of eight measurement, tape
circumference measurement and water displacement measurement.
Comfort will also be assessed by use of a 100mm non-hatched visual analogue scale (VAS).
Each participant will be asked to indicate their level of comfort following the application
of NMES. VAS pain scores of 30 mm or less will be categorised as mild pain, between 31 and
69 mm as moderate pain, and scores of 70 mm or greater as severe pain.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02316210 -
Optimization of Onpulse Technology for Patients With Post Surgical or Vascular Oedema
|
Phase 0 | |
| Completed |
NCT02114307 -
REVITIVE for the Treatment of Patients With Venous Insufficiency
|
N/A | |
| Completed |
NCT01887379 -
Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)
|
Phase 1 |